TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
19,453,532
|
16,354,993
|
14,848,809 |
| Financial expenses |
134,245
|
48,937
|
136,858 |
| Earnings before taxes |
5,570,801
|
7,458,093
|
-1,856,708 |
| EBITDA |
3,909,894
|
3,760,004
|
2,655,482 |
| Total assets |
38,897,662
|
32,917,808
|
24,268,127 |
| Current assets |
5,621,033
|
3,354,001
|
3,033,617 |
| Current liabilities |
3,473,556
|
2,187,545
|
2,242,121 |
| Equity capital |
31,149,560
|
27,987,626
|
19,006,335 |
| - share capital |
178,819
|
185,112
|
184,574 |
| Employees (average) |
7,543
|
7,248
|
6,875 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
80.1%
|
85.0%
|
78.3% |
| Turnover per employee |
2,579
|
2,256
|
2,160 |
| Profit as a percentage of turnover |
28.6%
|
45.6%
|
-12.5% |
| Return on assets (ROA) |
14.7%
|
22.8%
|
-7.1% |
| Current ratio |
161.8%
|
153.3%
|
135.3% |
| Return on equity (ROE) |
17.9%
|
26.6%
|
-9.8% |
| Change turnover |
3,654,551
|
1,462,960
|
4,598,995 |
| Change turnover % |
23%
|
10%
|
45% |
| Chg. No. of employees |
295
|
373
|
61 |
| Chg. No. of employees % |
4%
|
5%
|
1% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.